The GRFS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GRFS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The GRFS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View GRFS Detailed Price Forecast - CNN Money||View GRFS Detailed Summary - Google Finance|
|View GRFS Detailed Summary - Yahoo! Finance||View GRFS Stock Research & Analysis - Zacks.com|
|View GRFS Trends & Analysis - Trade-Ideas||View GRFS Major Holders - Barrons|
|View GRFS Call Transcripts - NASDAQ||View GRFS Breaking News & Analysis - Seeking Alpha|
|View GRFS Annual Report - CompanySpotlight.com||View GRFS OTC Short Report - OTCShortReport.com|
|View GRFS Fundamentals - TradeKing||View GRFS SEC Filings - Bar Chart|
|View Historical Prices for GRFS - The WSJ||View Performance/Total Return for GRFS - Morningstar|
|View the Analyst Estimates for GRFS - MarketWatch||View the Earnings History for GRFS - CNBC|
|View the GRFS Earnings - StockMarketWatch||View GRFS Buy or Sell Recommendations - MacroAxis|
|View the GRFS Bullish Patterns - American Bulls||View GRFS Short Pain Metrics - ShortPainBot.com|
|View GRFS Stock Mentions - StockTwits||View GRFS Stock Mentions - PennyStockTweets|
|View GRFS Stock Mentions - Twitter||View GRFS Investment Forum News - Investor Hub|
|View GRFS Stock Mentions - Yahoo! Message Board||View GRFS Stock Mentions - Seeking Alpha|
|View Insider Transactions for GRFS - SECform4.com||View Insider Transactions for GRFS - Insider Cow|
|View GRFS Major Holdings Summary - CNBC||View Insider Disclosure for GRFS - OTC Markets|
|View Insider Transactions for GRFS - Yahoo! Finance||View Institutional Holdings for GRFS - NASDAQ|
|View GRFS Stock Insight & Charts - FinViz.com||View GRFS Investment Charts - StockCharts.com|
|View GRFS Stock Overview & Charts - BarChart||View GRFS User Generated Charts - Trading View|
Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays
Posted on Tuesday June 19, 2018
- Grifols Procleix Ultrio Elite assay screens for HIV-1, HCV, and HBV and detects HIV-2; the Procleix WNV assay screens for West Nile virus - Both assays are approved to run on the fully automated NAT ...
2 Stable and 2 Speculative Biotech Stocks to Buy
Posted on Friday June 15, 2018
Biotech stocks represent a peculiar conundrum. Successes here could spark revolutionary therapies that could end or at least alleviate human suffering. Thus, creating a list of biotech stocks to buy will always be a tough challenge.
Factors of Influence in 2018, Key Indicators and Opportunity within Eldorado Gold, Lamar Advertising, Bitauto, Magellan Midstream Partners, Deutsche Bank Aktiengesellschaft, and Grifols, S.A. — New Research Emphasizes Economic Growth
Posted on Thursday June 07, 2018
NEW YORK, June 07, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Eldorado ...
Grifols Launches a New Testing Service for Patients Treated with Daratumumab
Posted on Thursday May 31, 2018
BARCELONA, Spain, May 31, 2018 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), one of the leading companies in the world in plasma-derived biological medicines and transfusion medicine, today announced it is adding a Daratumumab neutralization testing service to its extensive menu of services offered at Grifols Immunohematology Center laboratory (San Marcos, Texas). This new test facilitates complete antibody screening and identification in pretransfusion testing of patients under this therapy.